Summary
This study, published in Nature in 2025, investigates the role of nociceptive (pain-sensing) neurons in promoting gastric tumour progression, identifying a signalling axis between calcitonin gene-related peptide (CGRP) and its receptor component RAMP1 as a mechanistic driver. The research likely employs mouse models and human tissue data to demonstrate that neural inputs to the tumour microenvironment actively facilitate cancer growth rather than being passive bystanders. The findings contribute to the emerging field of cancer neuroscience by identifying a potential therapeutic target in the nerve–tumour interface of gastric malignancy.
UK applicability
Gastric cancer remains a significant cause of cancer mortality in the UK, and findings identifying novel neural signalling mechanisms in tumour progression may inform future therapeutic strategies relevant to UK oncology practice, though translational application will require clinical validation.
Key measures
Tumour growth metrics; CGRP peptide levels; RAMP1 receptor expression; nociceptive neuron density; potentially survival or proliferation markers in gastric tissue
Outcomes reported
The study investigated how pain-sensing (nociceptive) neurons influence gastric cancer progression through calcitonin gene-related peptide (CGRP) signalling via its receptor component RAMP1, likely measuring tumour growth, neural innervation, and downstream molecular pathway activity.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.